Scientists Elucidate How DREADD Technology Highjacks Neuronal Activity
December 8, 2022
The Bryan Roth lab got some nice press for their recent Nature paper, revealing structural details of his chemogenetic technology called DREADD – designer receptors exclusively activated by designer drugs - that recognize drug-like but physiologically inert compounds. Postdoc Shicheng Zhang, PhD, led this research published in Nature.